Regeneron (REGN) PALM Ebola Clinical Trial Stopped Early for Superiority

August 12, 2019 10:03 AM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company was informed by study investigators that a randomized, controlled ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot FDA News Management Comments

Next Articles